Kreon Finnancial (530139)
Fast GrowerScore breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹39.13 |
| Market Cap | ₹80.34 Cr |
| P/E Ratio | 10.86 |
| ROCE | -2.17% |
| ROE | 16.73% |
| Dividend Yield | 0% |
| Profit Growth | 128.76% |
| Debt/Equity | — |
| Sales Growth | 54.11% |
| 52-Week Range | ₹23.92 — ₹42.73 |
| Sector | Finance |
| Book Value | ₹17.99 |
Strengths
- Revenue growth of 54.11% and profit growth of 128.76% show strong recent momentum.
- PEG ratio of 0.12 indicates the market may be undervaluing the growth rate.
- ROE of 16.73% is above the average for Indian NBFCs.
- Piotroski F-Score of 6/9 suggests decent financial health.
- P/E of 10.86 is reasonable for a company with high near-term growth.
Concerns
- ROCE of -2.17% raises a red flag on actual operational returns.
- Zero dividend yield means no income support for shareholders.
- Debt/Equity and promoter holding data are unavailable, limiting assessment of leverage and alignment.
- Latest quarter profit of ₹1 Cr on ₹10 Cr sales may not sustain the trailing P/E if growth slows.
AI Analysis
At ₹39.13, Kreon Finnancial presents an intriguing but incomplete picture. A P/E of 10.86 and a PEG of 0.12 suggest the market is pricing in very little of the recent 128.76% profit growth and 54.11% sales growth. As Graham would say, numbers are the starting point, not the whole story. The ROE of 16.73% is respectable, and book value of ₹17.99 gives some support—though at P/B 2.18, you're paying a premium for that book. What worries me is ROCE at -2.17% for an NBFC; this suggests the core operating returns are not healthy, or there are measurement oddities. With no debt/equity data and no promoter holding disclosed, I cannot assess leverage or insider alignment. The latest quarter sales of ₹10 Cr and net profit of ₹1 Cr show a margin of 10%, but annualized that profit is far below what the P/E implies—so I must rely on the reported trailing P/E. This is a fast grower, but a fragile one. There is no dividend, so return must come solely from price appreciation. A F-Score of 6 out of 9 is passable, but not a clean bill of health. As Buffett, I prefer businesses with predictable cash flows and durable moats. Kreon is small, speculative, and data-deficient. I'd keep it on the watchlist, but only a very small position, if any, until leverage, promoter holding, and the profitability trajectory become clearer.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer